Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Diclofenac Sodium Gel 3% vs Solaraze in Actinic Keratosis
NCT01962987Phase 3Completed
- Sponsor
- Allergan
- Start
- Mar 2013
- Primary completion
- Sep 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of diclofenac in actinic keratosis (AK), sponsored by Allergan. Started Mar 2013; status: completed.
02
Drugs
diclofenac
03
Conditions
actinic keratosis (AK)
Beyond the preview
Go deeper on NCT01962987.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01962987.